Apogee Therapeutics, Inc. (APGE)
73.08
+2.16
(+3.05%)
USD |
NASDAQ |
Mar 06, 16:00
73.08
0.00 (0.00%)
After-Hours: 20:00
Apogee Therapeutics Cash from Investing (TTM) : -179.57M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Praxis Precision Medicines, Inc. | -311.15M |
| Celcuity, Inc. | -129.93M |
| Rhythm Pharmaceuticals, Inc. | -137.15M |
| Rapt Therapeutics, Inc. | -56.70M |
| Disc Medicine, Inc. | -394.30M |